the combination cytosine arabinoside ( ara-c ) , daunorubicin , and vp 16-213 was studied in 28 patients with acute non-lymphocytic leukemia to define the toxicity of the combination and assess its efficacy .
C0011015
daunorubicin
C0023467
acute non-lymphocytic leukemia